Aug 10, 2023
Scientists achieve world-changing nuclear fusion breakthrough — twice
Posted by Paul Battista in category: innovation
Doc Ock’s dream of holding the power of the sun in the palm of our hands may be coming true.
Doc Ock’s dream of holding the power of the sun in the palm of our hands may be coming true.
Take a look at the ingredients in any jar of moisturizer and it’ll almost certainly contain hyaluronic acid.
The gel-like substance helps your skin stretch and flex, and reduces lines and wrinkles. It also helps wounds to heal faster and can reduce scarring.
But hyaluronic acid, also known as hyaluron, is costly to produce and raises ethical concerns because it’s largely derived from animal tissue.
US scientists have achieved net energy gain in a nuclear fusion reaction for the second time since a historic breakthrough in December last year in the quest to find a near-limitless, safe and clean source of energy.
Scientists at the California-based Lawrence Livermore National Laboratory repeated the breakthrough in an experiment in the National Ignition Facility (NIF) on 30 July that produced a higher energy yield than in December, a Lawrence Livermore spokesperson said.
Aug 6 (Reuters) — U.S. scientists have achieved net energy gain in a fusion reaction for the second time since December, the Lawrence Livermore National Laboratory said on Sunday.
Scientists at the California-based lab repeated the fusion ignition breakthrough in an experiment in the National Ignition Facility (NIF) on July 30 that produced a higher energy yield than in December, a Lawrence Livermore spokesperson said.
Final results are still being analyzed, the spokesperson added.
A postdoctoral researcher at the University of Southern Denmark in Odense, Bilal studies the evolution of the novel in nineteenth-century literature. Yet he’s perhaps best known for his online tutorials, in which he serves as an informal ambassador between academics and the rapidly expanding universe of search tools that make use of artificial intelligence (AI).
Developers want to free scientists to focus on discovery and innovation by helping them to draw connections from a massive body of literature.
Chinese researchers have announced in a video that they’ve verified LK-99’s ability to conduct current with zero resistance, but questions still linger.
There are an estimated 30,000 instances of arc flash each year in the United States alone, and one to two fatalities occur daily in North America. Ontario Power Generation (OPG) has five Boston Dynamics’ Spot robots deployed throughout their Enterprise Innovation division. In 2022, the team sought to see if Spot’s dexterous arm could be used to assist in tripping and racking out a 600 volt breaker—an activity that is high risk for arc flash. Now, Boston Dynamics engineers have taken this application to the next level by fully automating the procedure. Spot can perform the entire operation autonomously, with a human issuing high level commands safely out of harm’s way.
#PowerGeneration #bostondynamics #Robotics #spot
The results of the study, Nadim II, from the Spanish Lung Cancer Group (GECP), have been published in the “New England Journal of Medicine” and endorse the great benefit of chemo-immunotherapy with nivolumab before operating on lung tumours in stage 3.
Nivolumab is a type of monoclonal antibody therapy, which works by stimulating the immune system to kill cancer cells.
Lung Cancer Treatment Breakthrough In Spain Could Increase Survival Rates by 20%.
CAR T-cell (chimeric antigen receptor) therapy, a promising form of immunotherapy, involves reprogramming the patient’s T cells to enhance their ability to identify and combat antigens on the surface of cancer cells.
However, this therapy, which is currently approved for the treatment of leukemia and lymphoma, has a significant downside. During the process of destroying cancer cells, many of the engineered T cells get contaminated with residual cancer antigens, leading them to attack fellow T cells. This eventually results in a decrease in the body’s population of cancer-fighting cells, opening the door for a recurrence of cancer.
A new Yale study, however, has identified a way to tame the self-destructive tendencies of these killer T cells. Simply fusing a molecular tail onto the engineered T cells used in therapy, researchers say, can inhibit their proclivity to attack each other. The study was published July 27 in the journal Nature Immunology.